Large-cell carcinoma, often classified in cases not assigned to adenocarcinoma or squamous cell carcinoma, shows mutations characteristic of NSCLC, such as KRAS and TP53 [24]. The gene discussed is TP53; the disease is squamous cell carcinoma.